|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000173546 |
Summary for CSPG4 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000173546 | Gene symbol | CSPG4 |
| Gene name | chondroitin sulfate proteoglycan 4 | |
| HGNC | 2466 | |
| Entrez ID | 1464 | |
| Gene type | protein_coding | |
| Synonyms | CSPG4|MCSPG|MEL-CSPG|MSK16|NG2|MCSP|HMW-MAA|CSPG4A | |
| UniProtAcc | Q6UVK1 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CSPG4 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CSPG4 | 2.64e+03 | -2.30e+00 | 4.94e-01 | -4.65e+00 | 3.29e-06 | 2.23e-05 | BLCA |
| CSPG4 | 6.16e+02 | -1.19e+00 | 3.19e-01 | -3.72e+00 | 1.96e-04 | 4.71e-04 | KIRP |
| CSPG4 | 2.09e+03 | 1.47e+00 | 3.07e-01 | 4.79e+00 | 1.70e-06 | 8.23e-06 | KICH |
| CSPG4 | 8.12e+02 | -1.91e+00 | 2.43e-01 | -7.86e+00 | 3.85e-15 | 4.54e-14 | COAD |
| CSPG4 | 9.53e+02 | 1.58e+00 | 5.16e-01 | 3.05e+00 | 2.25e-03 | 6.90e-03 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CSPG4 | 1.01e+03 | -1.75e+00 | 3.96e-01 | -4.41e+00 | 1.05e-05 | 6.76e-05 | READ |
Top |
Sex-biased somatic mutation for CSPG4 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CSPG4 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg02400942 | chr15:75713784 | CGI:chr15:75738223-75739341 | promoter | 6.69e-01 | 7.71e-01 | -2.52e+00 | 1.17e-02 | 2.83e-02 | -1.02e-01 |
| BRCA | cg03238581 | chr15:75713802 | CGI:chr15:75738223-75739341 | promoter | 7.36e-01 | 8.43e-01 | -2.33e+00 | 2.00e-02 | 3.49e-02 | -1.08e-01 |
| KICH | cg03238581 | chr15:75713802 | CGI:chr15:75738223-75739341 | promoter | 6.73e-01 | 5.47e-01 | 2.13e+00 | 3.32e-02 | 4.41e-02 | 1.26e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BLCA | cg21460582 | chr15:75713520 | CGI:chr15:75688957-75689259 | promoter | 6.91e-01 | 5.66e-01 | 3.32e+00 | 9.09e-04 | 2.11e-03 | 1.25e-01 |
| LIHC | cg09628962 | chr15:75712830 | CGI:chr15:75688957-75689259 | UTR,promoter,exon,gene body | 4.34e-01 | 2.53e-01 | 2.77e+00 | 5.64e-03 | 7.34e-03 | 1.81e-01 |
| ESCA | cg02400942 | chr15:75713784 | CGI:chr15:75738223-75739341 | promoter | 6.48e-01 | 4.77e-01 | 3.26e+00 | 1.13e-03 | 3.37e-02 | 1.71e-01 |
| ESCA | cg03238581 | chr15:75713802 | CGI:chr15:75738223-75739341 | promoter | 7.10e-01 | 5.17e-01 | 2.89e+00 | 3.87e-03 | 3.38e-02 | 1.94e-01 |
| CHOL | cg02400942 | chr15:75713784 | CGI:chr15:75738223-75739341 | promoter | 7.40e-01 | 5.03e-01 | 3.39e+00 | 6.96e-04 | 9.20e-03 | 2.38e-01 |
| CHOL | cg03238581 | chr15:75713802 | CGI:chr15:75738223-75739341 | promoter | 8.24e-01 | 5.57e-01 | 3.17e+00 | 1.52e-03 | 1.07e-02 | 2.67e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg09628962 | chr15:75712830 | CGI:chr15:75688957-75689259 | UTR,promoter,exon,gene body | 1.49e-01 | 3.39e-02 | 7.54e+00 | 4.54e-14 | 1.54e-13 | 1.15e-01 |
| BRCA | cg21460582 | chr15:75713520 | CGI:chr15:75688957-75689259 | promoter | 7.54e-01 | 6.48e-01 | 1.05e+01 | 6.75e-26 | 6.25e-25 | 1.06e-01 |
| BRCA | cg02400942 | chr15:75713784 | CGI:chr15:75738223-75739341 | promoter | 6.69e-01 | 4.73e-01 | 1.17e+01 | 1.01e-31 | 1.82e-30 | 1.96e-01 |
| BRCA | cg03238581 | chr15:75713802 | CGI:chr15:75738223-75739341 | promoter | 7.36e-01 | 4.86e-01 | 1.24e+01 | 3.11e-35 | 9.53e-34 | 2.49e-01 |
| LIHC | cg02400942 | chr15:75713784 | CGI:chr15:75738223-75739341 | promoter | 6.51e-01 | 5.05e-01 | 3.92e+00 | 8.82e-05 | 3.50e-04 | 1.46e-01 |
| LIHC | cg03238581 | chr15:75713802 | CGI:chr15:75738223-75739341 | promoter | 7.09e-01 | 5.45e-01 | 3.94e+00 | 8.16e-05 | 3.30e-04 | 1.64e-01 |
| KIRP | cg11698750 | chr15:75712848 | CGI:chr15:75688957-75689259 | promoter | 1.45e-01 | 3.39e-02 | 2.80e+00 | 5.08e-03 | 1.08e-02 | 1.11e-01 |
Top |
Exon skipping events with PSI in TCGA for CSPG4 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for CSPG4 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CSPG4 |
TFs related to CSPG4.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | PLAGL2 | CSPG4 | 4.43e+00 | 1.51e-02 | 5.52e+00 | 9.83e-01 | Female-biased |
| DLBC | PLAGL2 | CSPG4 | 4.48e+00 | 9.91e-01 | 3.24e+00 | 2.26e-03 | Male-biased |
| DLBC | ZNF816 | CSPG4 | 4.18e+00 | 9.82e-01 | 3.19e+00 | 6.01e-03 | Male-biased |
| ESCA | KLF10 | CSPG4 | 4.27e+00 | 9.90e-01 | 3.27e+00 | 2.07e-03 | Male-biased |
| ESCA | KLF3 | CSPG4 | 4.32e+00 | 9.90e-01 | 3.36e+00 | 2.52e-03 | Male-biased |
| ESCA | PATZ1 | CSPG4 | 4.32e+00 | 9.91e-01 | 3.29e+00 | 1.73e-03 | Male-biased |
| ESCA | PLAGL2 | CSPG4 | 4.60e+00 | 9.95e-01 | 3.33e+00 | 4.48e-04 | Male-biased |
| ESCA | TFAP2E | CSPG4 | 4.08e+00 | 9.80e-01 | 3.34e+00 | 8.74e-03 | Male-biased |
| ESCA | ZNF114 | CSPG4 | 4.52e+00 | 9.88e-01 | 3.72e+00 | 6.27e-03 | Male-biased |
| ESCA | ZNF141 | CSPG4 | 4.51e+00 | 9.93e-01 | 3.47e+00 | 1.67e-03 | Male-biased |
| ESCA | ZNF486 | CSPG4 | 4.41e+00 | 9.82e-01 | 3.71e+00 | 1.16e-02 | Male-biased |
| ESCA | ZNF530 | CSPG4 | 4.21e+00 | 9.86e-01 | 3.39e+00 | 5.43e-03 | Male-biased |
| ESCA | ZNF619 | CSPG4 | 4.19e+00 | 9.87e-01 | 3.33e+00 | 4.39e-03 | Male-biased |
| ESCA | ZNF682 | CSPG4 | 4.25e+00 | 9.86e-01 | 3.45e+00 | 6.03e-03 | Male-biased |
| ESCA | ZNF778 | CSPG4 | 4.40e+00 | 9.83e-01 | 3.70e+00 | 1.07e-02 | Male-biased |
| ESCA | ZNF816 | CSPG4 | 4.36e+00 | 9.91e-01 | 3.41e+00 | 2.68e-03 | Male-biased |
| ESCA | ZNF821 | CSPG4 | 4.64e+00 | 9.87e-01 | 3.88e+00 | 8.31e-03 | Male-biased |
CSPG4 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CSPG4 |
RBPs related to ES in CSPG4.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
CSPG4 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11630776 | chr15:78155448:C:G | - | 0.235798454907837 | 0.00429236051044803 | GBM | Female-baised eQTL |
| rs11631653 | chr15:78174255:C:T | - | 0.235798454907837 | 0.00429236051044803 | GBM | Female-baised eQTL |
| rs3087998 | chr15:78170176:C:T | - | 0.235908640223601 | 0.0185638743659687 | GBM | Female-baised eQTL |
| rs12905634 | chr15:78195330:G:C | - | 0.234414371679591 | 0.0195980504808073 | GBM | Female-baised eQTL |
| rs16971310 | chr15:79742126:G:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs60193233 | chr15:79742401:T:C | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs7174801 | chr15:79743847:A:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs201829531 | chr15:79745705:C:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs200935061 | chr15:79745983:T:C | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs148281232 | chr15:79746357:A:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs146289559 | chr15:79748069:C:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs188068157 | chr15:79748185:T:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs192479341 | chr15:79750465:G:T | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs8034508 | chr15:79750741:A:T | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs140278700 | chr15:79750793:G:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs1079218 | chr15:79751292:G:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs2013592 | chr15:79751412:G:C | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs2013599 | chr15:79751525:G:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs3937731 | chr15:79751805:A:C | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs2866107 | chr15:79751884:T:C | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs2866106 | chr15:79752030:C:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs1809944 | chr15:79752052:C:T | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs2013802 | chr15:79752090:G:T | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs4622472 | chr15:79752276:G:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs56226412 | chr15:79752437:C:T | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs60628571 | chr15:79752490:A:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs62026576 | chr15:79754439:A:C | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs74027635 | chr15:79754540:C:G | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs8032529 | chr15:79755298:G:A | - | 0.171491517315021 | 0.000233047482957104 | LUSC | Female-baised eQTL |
| rs149834368 | chr15:79745371:C:T | - | 0.171299787308088 | 0.00024345384916096 | LUSC | Female-baised eQTL |
| rs1809945 | chr15:79751985:A:G | - | 0.115752702758624 | 0.00451608106392087 | LUSC | Female-baised eQTL |
| rs4779148 | chr15:79754679:A:G | - | 0.0977531038102395 | 0.0235786913118239 | LUSC | Female-baised eQTL |
| rs4779152 | chr15:79756914:A:G | - | 0.102162385691865 | 0.0364217468207823 | LUSC | Female-baised eQTL |
| rs4572339 | chr15:71626866:T:C | - | -0.0496363824449284 | 0.0457464317313602 | LGG | Female-baised eQTL |
| rs9972354 | chr15:66571156:A:G | - | 0.130471732403656 | 0.00675125851476004 | BLCA | Female-baised eQTL |
| rs6494568 | chr15:66360560:T:A | - | -0.0920247798951645 | 0.0295906206765331 | BLCA | Female-baised eQTL |
| rs4776784 | chr15:66386041:T:G | - | -0.0920247798951645 | 0.0295906206765331 | BLCA | Female-baised eQTL |
| rs7181197 | chr15:66437773:T:C | - | -0.0880467820442598 | 0.0407227665027376 | BLCA | Female-baised eQTL |
| rs6494573 | chr15:66443213:C:T | - | -0.0880467820442598 | 0.0407227665027376 | BLCA | Female-baised eQTL |
| rs8027717 | chr15:66457187:C:T | - | -0.0880467820442598 | 0.0407227665027376 | BLCA | Female-baised eQTL |
| rs8032412 | chr15:66457292:G:A | - | -0.0880467820442598 | 0.0407227665027376 | BLCA | Female-baised eQTL |
| rs12050736 | chr15:66458313:C:T | - | -0.0880467820442598 | 0.0407227665027376 | BLCA | Female-baised eQTL |
| rs35073258 | chr15:66526584:C:T | - | 0.0941922328797854 | 0.0430664026817527 | BLCA | Female-baised eQTL |
| rs74028684 | chr15:81466826:T:C | - | 0.0423153595332997 | 0.00952717329863522 | LUAD | Female-baised eQTL |
| rs1054259 | chr15:71780158:C:T | - | -0.0468005968507074 | 0.0120509352390853 | LUAD | Female-baised eQTL |
| rs10468050 | chr15:71781600:C:G | - | -0.0459814525938497 | 0.013497492899835 | LUAD | Female-baised eQTL |
| rs74028681 | chr15:81464786:A:G | - | 0.0390044989762945 | 0.0135263193606238 | LUAD | Female-baised eQTL |
| rs58843277 | chr15:81465529:A:G | - | 0.0382952935052335 | 0.0152492133620305 | LUAD | Female-baised eQTL |
| rs11858255 | chr15:81464598:A:C | - | 0.0371405040303133 | 0.0190439790644472 | LUAD | Female-baised eQTL |
| rs28587194 | chr15:81461769:C:T | - | 0.0345756051107744 | 0.0238691509435616 | LUAD | Female-baised eQTL |
| rs7167421 | chr15:81461102:C:T | - | 0.0332004649099839 | 0.0269971371732615 | LUAD | Female-baised eQTL |
| rs6495584 | chr15:81452006:G:A | - | 0.0392719973381636 | 0.02852202350857 | LUAD | Female-baised eQTL |
| rs73438759 | chr15:81459072:C:T | - | 0.0335472618241948 | 0.0300482725051239 | LUAD | Female-baised eQTL |
| rs28895340 | chr15:81459486:T:C | - | 0.0341233370065946 | 0.0331913398995983 | LUAD | Female-baised eQTL |
| rs113742479 | chr15:81437202:G:A | - | 0.0356951582936832 | 0.0368591048478287 | LUAD | Female-baised eQTL |
| rs7183444 | chr15:81459992:G:A | - | 0.0334245484352361 | 0.037177644250155 | LUAD | Female-baised eQTL |
| rs77284159 | chr15:74275229:A:G | - | 0.147743298683344 | 3.98679616061206e-05 | COAD | Female-baised eQTL |
| rs74329782 | chr15:74277342:G:T | - | 0.14415837807288 | 0.000461969808972002 | COAD | Female-baised eQTL |
| rs8035484 | chr15:74278338:C:T | - | 0.14415837807288 | 0.000461969808972002 | COAD | Female-baised eQTL |
| rs8031291 | chr15:74278235:C:T | - | 0.101933491381783 | 0.0193560025078363 | COAD | Female-baised eQTL |
| rs7166315 | chr15:79740432:C:T | - | 0.086698189737457 | 0.0486082715749095 | COAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs74889224 | chr15:80675713:G:A | - | 0.0580217083289934 | 0.00124091127048553 | LUSC | Male-baised eQTL |
| rs78152946 | chr15:78867001:G:C | - | 0.080899753233179 | 0.0334911300743531 | STAD | Male-baised eQTL |
| rs74614608 | chr15:78871536:G:A | - | 0.080899753233179 | 0.0334911300743531 | STAD | Male-baised eQTL |
| rs113850146 | chr15:78872608:C:A | - | 0.080899753233179 | 0.0334911300743531 | STAD | Male-baised eQTL |
| rs76770078 | chr15:78873268:G:A | - | 0.080899753233179 | 0.0334911300743531 | STAD | Male-baised eQTL |
| rs75888439 | chr15:78876923:T:C | - | 0.080899753233179 | 0.0334911300743531 | STAD | Male-baised eQTL |
| rs113198676 | chr15:78879365:G:A | - | 0.080899753233179 | 0.0334911300743531 | STAD | Male-baised eQTL |
| rs28433466 | chr15:81570679:C:G | - | 0.0855230358601781 | 0.0485504249994573 | STAD | Male-baised eQTL |
| rs8032930 | chr15:80308968:A:G | - | 0.106785416932479 | 0.048209874537068 | KIRC | Male-baised eQTL |
| rs16972671 | chr15:81040336:A:C | - | 0.0926677998605966 | 0.00847099248044124 | BLCA | Male-baised eQTL |
| rs78386597 | chr15:71533332:C:T | - | 0.174112168325015 | 0.000578285459942425 | LUAD | Male-baised eQTL |
| rs78043771 | chr15:71536828:T:G | - | 0.164528511649112 | 0.00159177476810371 | LUAD | Male-baised eQTL |
| rs76167267 | chr15:71539718:A:T | - | 0.164528511649112 | 0.00159177476810371 | LUAD | Male-baised eQTL |
| rs80184477 | chr15:71542238:C:T | - | 0.162053195655347 | 0.00222380846377495 | LUAD | Male-baised eQTL |
| rs74702525 | chr15:71535470:C:T | - | 0.161214447041688 | 0.00244625557484001 | LUAD | Male-baised eQTL |
| rs77110678 | chr15:71535474:T:G | - | 0.161214447041688 | 0.00244625557484001 | LUAD | Male-baised eQTL |
| rs77666942 | chr15:71537005:G:A | - | 0.156217559348332 | 0.00359162745933125 | LUAD | Male-baised eQTL |
| rs112372355 | chr15:71540613:G:C | - | 0.155909589506677 | 0.00376610392115135 | LUAD | Male-baised eQTL |
| rs75486054 | chr15:71537274:G:A | - | 0.149429574077206 | 0.00648049931175803 | LUAD | Male-baised eQTL |
| rs112418455 | chr15:71538050:G:A | - | 0.149429574077206 | 0.00648049931175803 | LUAD | Male-baised eQTL |
| rs12441823 | chr15:67620639:C:T | - | 0.0858970592818123 | 0.00787034876181673 | LUAD | Male-baised eQTL |
| rs3865018 | chr15:67600428:C:T | - | 0.0818502093281328 | 0.00974677861988344 | LUAD | Male-baised eQTL |
| rs12902812 | chr15:67616941:G:A | - | 0.0828469686874789 | 0.0111324063067437 | LUAD | Male-baised eQTL |
| rs4776943 | chr15:67543731:T:C | - | 0.0812355297368231 | 0.0115661603842987 | LUAD | Male-baised eQTL |
| rs4776361 | chr15:67469718:G:A | - | 0.079253514904139 | 0.0122303386295172 | LUAD | Male-baised eQTL |
| rs12441715 | chr15:67568249:G:A | - | 0.0810635095915177 | 0.0124003490204159 | LUAD | Male-baised eQTL |
| rs78037073 | chr15:71557523:G:A | - | 0.137743103866074 | 0.0138178990134887 | LUAD | Male-baised eQTL |
| rs28673019 | chr15:67517485:T:A | - | 0.0802263782053152 | 0.0160889049963135 | LUAD | Male-baised eQTL |
| rs4776942 | chr15:67524877:G:T | - | 0.0802263782053152 | 0.0160889049963135 | LUAD | Male-baised eQTL |
| rs34765730 | chr15:67643682:G:A | - | 0.087144719828794 | 0.0164876761173477 | LUAD | Male-baised eQTL |
| rs4776370 | chr15:67612173:T:C | - | 0.0801869351671904 | 0.0171414647400069 | LUAD | Male-baised eQTL |
| rs28645602 | chr15:67238985:A:G | - | 0.0842816135726362 | 0.0175655668609766 | LUAD | Male-baised eQTL |
| rs2289789 | chr15:67240045:C:T | - | 0.0842816135726362 | 0.0175655668609766 | LUAD | Male-baised eQTL |
| rs7182798 | chr15:67242874:C:G | - | 0.0842816135726362 | 0.0175655668609766 | LUAD | Male-baised eQTL |
| rs4776908 | chr15:67247749:T:C | - | 0.0842816135726362 | 0.0175655668609766 | LUAD | Male-baised eQTL |
| rs2033783 | chr15:67215430:C:T | - | 0.0842772872010282 | 0.0182187799470496 | LUAD | Male-baised eQTL |
| rs72625777 | chr15:67211470:G:C | - | 0.0840179685302727 | 0.018604617699974 | LUAD | Male-baised eQTL |
| rs8026870 | chr15:67219051:G:A | - | 0.0840179685302727 | 0.018604617699974 | LUAD | Male-baised eQTL |
| rs35322464 | chr15:67219152:A:G | - | 0.0840179685302727 | 0.018604617699974 | LUAD | Male-baised eQTL |
| rs8031500 | chr15:67226702:C:T | - | 0.0840179685302727 | 0.018604617699974 | LUAD | Male-baised eQTL |
| rs12915085 | chr15:67229800:C:G | - | 0.0840179685302727 | 0.018604617699974 | LUAD | Male-baised eQTL |
| rs12900758 | chr15:67230705:A:G | - | 0.0840179685302727 | 0.018604617699974 | LUAD | Male-baised eQTL |
| rs35688953 | chr15:67347791:T:C | - | 0.0831445337488426 | 0.021407228987031 | LUAD | Male-baised eQTL |
| rs12915438 | chr15:67634360:C:T | - | 0.084935545393028 | 0.0214625358968056 | LUAD | Male-baised eQTL |
| rs7169086 | chr15:67642116:C:T | - | 0.084282608761415 | 0.0217882612923289 | LUAD | Male-baised eQTL |
| rs28418298 | chr15:67643407:C:T | - | 0.0840129884184357 | 0.0232722670845491 | LUAD | Male-baised eQTL |
| rs28565266 | chr15:67645673:C:G | - | 0.0840129884184357 | 0.0232722670845491 | LUAD | Male-baised eQTL |
| rs2414952 | chr15:67432054:A:T | - | 0.0782973249225729 | 0.0240797304600056 | LUAD | Male-baised eQTL |
| rs12905371 | chr15:67553592:C:T | - | 0.0768583305834809 | 0.025411714600079 | LUAD | Male-baised eQTL |
| rs28399271 | chr15:67417673:G:A | - | 0.0782918066744581 | 0.0256607212762135 | LUAD | Male-baised eQTL |
| rs35930676 | chr15:67535367:G:A | - | 0.0772682755689466 | 0.0261620773266257 | LUAD | Male-baised eQTL |
| rs8030034 | chr15:84941484:C:T | - | 0.085145153565717 | 0.0286760965682273 | LUAD | Male-baised eQTL |
| rs8030045 | chr15:84941500:C:T | - | 0.085145153565717 | 0.0286760965682273 | LUAD | Male-baised eQTL |
| rs113259192 | chr15:84936145:C:T | - | 0.0827929331982074 | 0.0336021328234033 | LUAD | Male-baised eQTL |
| rs4980342 | chr15:84940771:C:T | - | 0.0836886403442139 | 0.0340410560275137 | LUAD | Male-baised eQTL |
| rs28735117 | chr15:67641554:C:T | - | 0.078952514855917 | 0.0397527288906736 | LUAD | Male-baised eQTL |
| rs12438118 | chr15:67658812:G:T | - | 0.0768573177807773 | 0.0459195496529391 | LUAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg02400942 | chr15:75713784 | promoter | -0.354159840104696 | 6.99927372648431e-08 | -0.40747213502746216 | 1.931532823194475e-09 | KIRP |
| cg02400942 | chr15:75713784 | promoter | -0.430615425028291 | 2.41269190977096e-15 | -0.48614060218571686 | 1.5062047614609134e-18 | LGG |
| cg03238581 | chr15:75713802 | promoter | -0.430615425028291 | 2.41269190977096e-15 | -0.48614060218571686 | 1.5062047614609134e-18 | LGG |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CSPG4 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000173546 | CSPG4 | C2239176 | Liver carcinoma | 1 | CTD_human |